Canada markets closed

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
71.52+0.35 (+0.49%)
At close: 04:00PM EDT
71.52 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-239,238
-239,238
-187,134
-130,403
-102,901
Depreciation & amortization
6,834
6,834
4,402
76
77.718
Stock based compensation
62,620
62,620
37,726
20,803
14,756
Change in working capital
-28,392
-28,392
23,670
324
412.041
Accounts receivable
-57,121
-57,121
-37,699
0
0
Inventory
-4,462
-4,462
-5,275
-6
-177.5
Accounts Payable
2,074
2,074
25,456
-355
2,561
Other working capital
-145,662
-145,662
-117,213
-108,534
-78,502
Other non-cash items
53,096
53,096
4,825
974
7,951
Net cash provided by operating activites
-145,080
-145,080
-116,511
-108,226
-78,457
Cash flows from investing activities
Investments in property, plant and equipment
-582
-582
-702
-308
-45.891
Acquisitions, net
0
0
-53,000
0
0
Net cash used for investing activites
-582
-582
-53,702
-308
-45.891
Cash flows from financing activities
Debt repayment
-
-
0
0
-21,660
Common stock issued
258,750
258,750
243,763
7,436
14,126
Other financing activites
-25,156
-25,156
-10,432
-708
-1,103
Net cash used privided by (used for) financing activities
331,013
331,013
284,582
11,130
42,413
Net change in cash
185,351
185,351
114,369
-97,404
-36,090
Cash at beginning of period
200,842
200,842
86,473
183,877
219,966
Cash at end of period
386,193
386,193
200,842
86,473
183,876
Free Cash Flow
Operating Cash Flow
-145,080
-145,080
-116,511
-108,226
-78,457
Capital Expenditure
-582
-582
-702
-308
-45.891
Free Cash Flow
-145,662
-145,662
-117,213
-108,534
-78,502